Skip to main content

Published locations for ALTA-1L: Brigatinib beats crizotinib for PFS in ALK-positive NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ALTA-1L: Brigatinib beats crizotinib for PFS in ALK-positive NSCLC

User login

  • Reset your password
  • /content/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive-nsclc
  • /internalmedicinenews/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive
  • /oncologypractice/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive
  • /hematology-oncology/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive
  • /internalmedicine/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive
  • /chestphysician/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk-positive-nsclc
  • /b-cell-lymphoma-icymi/article/176773/lung-cancer/alta-1l-brigatinib-beats-crizotinib-pfs-alk